<?xml version='1.0' encoding='UTF-8'?>
<article doi="10.15252/emmm.202114501"><fig id="45776"><title>.</title><label>Figure 1</label><graphic href="https://api.sourcedata.io/file.php?figure_id=45776"/><sd-panel panel_id="123966">A, B <sd-pretag id="sdPretag1681485507sm" type="geneprod" role="intervention">CB17</sd-pretag>-SCID male <sd-pretag id="sdPretag1031761598sm" type="organism" role="component">mice</sd-pretag> were injected intramuscularly into the <sd-pretag id="sdPretag1192265794sm" type="tissue" role="component">hind leg muscles</sd-pretag> with (A) <sd-pretag id="sdPretag887679524sm" type="geneprod" role="intervention">BRCA2</sd-pretag>-proficient (<em><sd-pretag id="sdPretag2085791564sm" type="geneprod" role="intervention">BRCA2</sd-pretag><sup>+/+</sup></em>) or (B) <sd-pretag id="sdPretag1483694250sm" category="disease">BRCA2</sd-pretag><sd-pretag id="sdPretag1310211112sm" category="disease">-deficient</sd-pretag> (<em><sd-pretag id="sdPretag570515491sm" type="geneprod" role="intervention">BRCA2</sd-pretag><sup>-/-</sup></em>) <sd-pretag id="sdPretag1052152391sm" type="cell" role="component">DLD1</sd-pretag> cells. <sd-pretag id="sdPretag759172867sm" type="small" role="intervention">Pyridostatin</sd-pretag> (<sd-pretag id="sdPretag97777475sd" parent-tag-id="8">PDS</sd-pretag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>) and <sd-pretag id="sdPretag343138789sm" type="small" role="intervention">talazoparib</sd-pretag> was administered orally (<em>p.o.; 0.33 mg/kg/day</em>), over the indicated periods of <sd-pretag id="sdPretag247879293sd" parent-tag-id="85">time</sd-pretag>. Vertical dashed line indicates end of treatment. <sd-pretag id="sdPretag491092191sm" type="tissue" role="component">Tumour</sd-pretag> <sd-pretag id="sdPretag1640625920sm" category="assay">volume</sd-pretag> was measured at the timepoints shown on the graph and expressed relative to <sd-pretag id="sdPretag1009833345sm" category="disease">tumour</sd-pretag> volume at the beginning of treatment. Each experimental group included <em>n</em> = 5 <sd-pretag id="sdPretag323648946sm" type="organism" role="component">mice</sd-pretag>. Error bars represent SEM. <em>P</em> values were calculated between treated and untreated <sd-pretag id="sdPretag1725320818sm" category="disease">tumours</sd-pretag> at day 17, using an unpaired two-tailed <em>t</em>-test. ***, <em>P</em> ≤ 0.001; <em>NS</em>, <em>P</em> &gt; 0.5. <graphic href="https://api.sourcedata.io/file.php?panel_id=123966"/></sd-panel><sd-panel panel_id="123967">C <sd-tag id="sdTag136" source="sdapi" category="None" entity_type="subcellular" role="assayed" text="DNA" ext_ids="GO:0005574" ext_dbs="" in_caption="True" ext_names="DNA" ext_tax_ids="" ext_tax_names="" ext_urls="http://amigo.geneontology.org/amigo/term/">DNA</sd-tag> breaks were measured using <sd-tag id="sdTag1" source="sdapi" category="assay" entity_type="None" role="None" text="alkaline comet assay" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">alkaline comet assay</sd-tag> in <sd-tag id="sdTag2" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>-proficient (+<sd-tag id="sdTag3" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>) or -deficient (-<sd-tag id="sdTag4" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>) <sd-tag id="sdTag5" source="sdapi" category="None" entity_type="organism" role="component" text="human" ext_ids="9606" ext_dbs="" in_caption="True" ext_names="Homo sapiens" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">human</sd-tag> <sd-tag id="sdTag6" source="sdapi" category="None" entity_type="cell" role="assayed" text="DLD1" ext_ids="CVCL_0248" ext_dbs="" in_caption="True" ext_names="DLD-1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">DLD1</sd-tag> cells treated with 2 µM <sd-tag id="sdTag7" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag> (<sd-tag id="sdTag8" source="sdapi" category="None" entity_type="molecule" role="intervention" text="PDS" ext_ids="25227847" ext_dbs="" in_caption="True" ext_names="Pyridostatin" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">PDS</sd-tag>) for 16 hours and released into fresh medium without <sd-tag id="sdTag9" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag>. Representative images are shown. Scale bar represents 100 µm. <p><strong>D</strong> Quantification of <sd-tag id="sdTag137" source="sdapi" category="None" entity_type="subcellular" role="assayed" text="DNA" ext_ids="GO:0005574" ext_dbs="" in_caption="True" ext_names="DNA" ext_tax_ids="" ext_tax_names="" ext_urls="http://amigo.geneontology.org/amigo/term/">DNA</sd-tag> breaks shown in (C). Graph and error bars represent the mean and SEM of <em>n</em> = 3 independent experiments. A minimum of 50 cells were analysed per condition per experiment. <em>P</em> values were calculated using an unpaired two-tailed <em>t</em>-test. *, <em>P</em> ≤ 0.05; <em>NS</em>, <em>P</em> &gt; 0.5.</p> <p><strong>E</strong> Quantification of <sd-tag id="sdTag10" source="sdapi" category="None" entity_type="protein" role="assayed" text="γH2AX" ext_ids="P16104" ext_dbs="" in_caption="True" ext_names="H2AX" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">γH2AX</sd-tag> foci visualised using <sd-tag id="sdTag11" source="sdapi" category="assay" entity_type="None" role="None" text="immunofluorescence" ext_ids="BAO_0000450" ext_dbs="" in_caption="True" ext_names="fluorescence microscopy" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">immunofluorescence</sd-tag> <sd-tag id="sdTag12" source="sdapi" category="assay" entity_type="None" role="None" text="staining" ext_ids="OBI_0302887" ext_dbs="" in_caption="True" ext_names="staining" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ontobee.org/ontology/OBI?iri=http://purl.obolibrary.org/obo/">staining</sd-tag> in cells treated as in (C). A minimum of 200 cells were analysed per condition per experiment. Graph and error bars represent the mean and SEM of <em>n</em> = 3 independent experiments. <em>P</em> values were calculated using an unpaired two-tailed <em>t</em>-test. ***, <em>P</em> ≤ 0.001; <em>NS</em>, <em>P</em> &gt; 0.5.</p> <graphic href="https://api.sourcedata.io/file.php?panel_id=123967"/></sd-panel><sd-panel panel_id="123968">F <sd-tag id="sdTag15" source="sdapi" category="None" entity_type="gene" role="component" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>-deficient (-<sd-tag id="sdTag16" source="sdapi" category="None" entity_type="gene" role="component" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>) <sd-tag id="sdTag17" source="sdapi" category="None" entity_type="organism" role="component" text="human" ext_ids="9606" ext_dbs="" in_caption="True" ext_names="Homo sapiens" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">human</sd-tag> <sd-tag id="sdTag18" source="sdapi" category="None" entity_type="cell" role="component" text="DLD1" ext_ids="CVCL_0248" ext_dbs="" in_caption="True" ext_names="DLD-1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">DLD1</sd-tag> cells were treated with 2 µM <sd-tag id="sdTag19" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag> (<sd-tag id="sdTag20" source="sdapi" category="None" entity_type="molecule" role="intervention" text="PDS" ext_ids="25227847" ext_dbs="" in_caption="True" ext_names="Pyridostatin" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">PDS</sd-tag>) for 24 hours. Next, <sd-tag id="sdTag21" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag> was removed and cells were released in a medium containing 250 nM <sd-tag id="sdTag22" source="sdapi" category="None" entity_type="molecule" role="intervention" text="NU-7441" ext_ids="11327430" ext_dbs="" in_caption="True" ext_names="503468-95-9" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">NU-7441</sd-tag> (<sd-tag id="sdTag23" source="sdapi" category="None" entity_type="molecule" role="intervention" text="NU" ext_ids="103456957" ext_dbs="" in_caption="True" ext_names="NU-7441" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/substance/">NU</sd-tag>). Whole-cell extracts were prepared at the indicated <sd-tag id="sdTag24" source="sdapi" category="time" entity_type="None" role="None" text="timepoints" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">timepoints</sd-tag> after release and <sd-tag id="sdTag25" source="sdapi" category="assay" entity_type="None" role="None" text="immunoblotted" ext_ids="BAO_0002422" ext_dbs="" in_caption="True" ext_names="immunoblot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">immunoblotted</sd-tag> as shown. <sd-tag id="sdTag26" source="sdapi" category="None" entity_type="protein" role="normalizing" text="SMC1" ext_ids="Q8NDV3///Q14683" ext_dbs="" in_caption="True" ext_names="SMC1B///SMC1A" ext_tax_ids="9606///9606" ext_tax_names="Homo sapiens///Homo sapiens" ext_urls="https://www.uniprot.org/uniprot////https://www.uniprot.org/uniprot/">SMC1</sd-tag> was used as a loading control. <sd-tag id="sdTag27" source="sdapi" category="None" entity_type="protein" role="assayed" text="KAP1" ext_ids="Q13263" ext_dbs="" in_caption="True" ext_names="TRIM28" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">KAP1</sd-tag> <sd-tag id="sdTag28" source="sdapi" category="assay" entity_type="None" role="None" text="phosphorylation" ext_ids="BAO_0003005" ext_dbs="" in_caption="True" ext_names="phosphorylation assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">phosphorylation</sd-tag> site is indicated in red. <graphic href="https://api.sourcedata.io/file.php?panel_id=123968"/></sd-panel><sd-panel panel_id="123969">G <sd-tag id="sdTag138" source="sdapi" category="assay" entity_type="None" role="None" text="Dose-dependent" ext_ids="OBI_0001418" ext_dbs="" in_caption="True" ext_names="dose response design" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ontobee.org/ontology/OBI?iri=http://purl.obolibrary.org/obo/">Dose-dependent</sd-tag> <sd-tag id="sdTag29" source="sdapi" category="assay" entity_type="None" role="None" text="viability assays" ext_ids="BAO_0000127" ext_dbs="" in_caption="True" ext_names="viability measurement method" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">viability assays</sd-tag> of <sd-tag id="sdTag30" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>-proficient (+<sd-tag id="sdTag31" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>) or -deficient (-<sd-tag id="sdTag32" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>) <sd-tag id="sdTag33" source="sdapi" category="None" entity_type="organism" role="component" text="human" ext_ids="9606" ext_dbs="" in_caption="True" ext_names="Homo sapiens" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">human</sd-tag> <sd-tag id="sdTag34" source="sdapi" category="None" entity_type="cell" role="assayed" text="DLD1" ext_ids="CVCL_0248" ext_dbs="" in_caption="True" ext_names="DLD-1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">DLD1</sd-tag> cells treated with <sd-tag id="sdTag35" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag> (<sd-tag id="sdTag36" source="sdapi" category="None" entity_type="molecule" role="intervention" text="PDS" ext_ids="25227847" ext_dbs="" in_caption="True" ext_names="Pyridostatin" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">PDS</sd-tag>) and <sd-tag id="sdTag37" source="sdapi" category="None" entity_type="molecule" role="intervention" text="NU-7441" ext_ids="11327430" ext_dbs="" in_caption="True" ext_names="503468-95-9" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">NU-7441</sd-tag> at the indicated concentrations for six days. Graphs represent average values obtained from <strong>of</strong> <em>n</em> = 3 independent experiments, each performed in technical triplicates. <graphic href="https://api.sourcedata.io/file.php?panel_id=123969"/></sd-panel></fig><fig id="45777"><title>.</title><label>Figure 2</label><graphic href="https://api.sourcedata.io/file.php?figure_id=45777"/><sd-panel panel_id="123970">H1299+shBRCA2<sup>DOX</sup> cells were grown for 4 days in the presence (-<sd-pretag id="sdPretag938540275sd" type="geneprod" role="component">BRCA2</sd-pretag>) or absence (+<sd-pretag id="sdPretag1421584233sd" type="geneprod" role="component">BRCA2</sd-pretag>) of <sd-pretag id="sdPretag602582688sd" type="molecule" role="component">DOX</sd-pretag> and subsequently treated with 5 or 10 μM <sd-pretag id="sdPretag445785623sd" parent-tag-id="7">pyridostatin</sd-pretag> (<sd-pretag id="sdPretag1326083338sd" parent-tag-id="8">PDS</sd-pretag>) for 3 days. Whole-cell extracts were immunoblotted as indicated. <sd-pretag id="sdPretag1722497923sd" type="geneprod" role="component">KAP1</sd-pretag> and <sd-pretag id="sdPretag1823522176sd" type="geneprod" role="component">IRF3</sd-pretag> phosphorylation sites are shown in red. <sd-pretag id="sdPretag1873873347sd" type="geneprod" role="normalizing">SMC1</sd-pretag> and <sd-pretag id="sdPretag2034062655sd" type="geneprod" role="normalizing">GAPDH</sd-pretag> were used as loading controls. <graphic href="https://api.sourcedata.io/file.php?panel_id=123970"/></sd-panel><sd-panel panel_id="123971">H1299+shBRCA2<sup>DOX</sup> cells were grown for 4 days in the presence or absence of <sd-pretag id="sdPretag1378411471sd" type="molecule" role="component">DOX</sd-pretag> and subsequently treated with 10 μM <sd-pretag id="sdPretag1764629840sd" parent-tag-id="7">pyridostatin</sd-pretag> (<sd-pretag id="sdPretag828313595sd" parent-tag-id="8">PDS</sd-pretag>) for 1, 2 or 3 days. Whole-cell extracts were immunoblotted as indicated. <sd-pretag id="sdPretag359676716sd" type="geneprod" role="component">KAP1</sd-pretag> and <sd-pretag id="sdPretag1769599945sd" type="geneprod" role="component">IRF3</sd-pretag> phosphorylation sites are shown in red. <sd-pretag id="sdPretag1521526267sd" type="geneprod" role="normalizing">SMC1</sd-pretag> and <sd-pretag id="sdPretag1556686702sd" type="geneprod" role="normalizing">GAPDH</sd-pretag> were used as loading controls. <graphic href="https://api.sourcedata.io/file.php?panel_id=123971"/></sd-panel><sd-panel panel_id="123972"><sd-tag id="sdTag39" source="sdapi" category="assay" entity_type="None" role="None" text="Quantitative RT-PCR" ext_ids="BAO_0002090" ext_dbs="" in_caption="True" ext_names="quantitative reverse transcription PCR" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">Quantitative RT-PCR</sd-tag> of cells grown as in (A) and treated with 10 µM <sd-tag id="sdTag40" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag> (<sd-tag id="sdTag41" source="sdapi" category="None" entity_type="molecule" role="intervention" text="PDS" ext_ids="25227847" ext_dbs="" in_caption="True" ext_names="Pyridostatin" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">PDS</sd-tag>) for 3 days was performed using primers specific for the indicated genes. mRNA levels are expressed relative to <sd-tag id="sdTag42" source="sdapi" category="None" entity_type="gene" role="normalizing" text="GAPDH" ext_ids="2597" ext_dbs="" in_caption="True" ext_names="GAPDH" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">GAPDH</sd-tag> and to -<sd-tag id="sdTag43" source="sdapi" category="None" entity_type="molecule" role="component" text="DOX" ext_ids="CHEBI:50845" ext_dbs="" in_caption="True" ext_names="doxycycline" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">DOX</sd-tag> (+<sd-tag id="sdTag44" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag>) cells. Error bars represent the SEM of <em>n</em> = 3 independent experiments, each performed in technical triplicate. <em>P</em> values were calculated using an unpaired two-tailed <em>t</em>-test. *, <em>P</em> ≤ 0.05; ***, <em>P</em> ≤ 0.001. <graphic href="https://api.sourcedata.io/file.php?panel_id=123972"/></sd-panel><sd-panel panel_id="123973"><sd-tag id="sdTag49" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag><sup>+/+</sup> and <em><sd-tag id="sdTag50" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag></em><sup>-/-</sup> <sd-tag id="sdTag51" source="sdapi" category="None" entity_type="cell" role="component" text="RPE-1" ext_ids="CVCL_4388&#10;" ext_dbs="" in_caption="True" ext_names="hTERT-RPE1&#10;" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">RPE-1</sd-tag> cells were treated with 10 μM <sd-tag id="sdTag52" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag> (<sd-tag id="sdTag53" source="sdapi" category="None" entity_type="molecule" role="intervention" text="PDS" ext_ids="25227847" ext_dbs="" in_caption="True" ext_names="Pyridostatin" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">PDS</sd-tag>) for 2 days. Whole-cell extracts were <sd-tag id="sdTag54" source="sdapi" category="assay" entity_type="None" role="None" text="immunoblotted" ext_ids="BAO_0002422" ext_dbs="" in_caption="True" ext_names="immunoblot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">immunoblotted</sd-tag> as indicated. <sd-tag id="sdTag55" source="sdapi" category="None" entity_type="protein" role="assayed" text="KAP1" ext_ids="Q13263" ext_dbs="" in_caption="True" ext_names="TRIM28" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">KAP1</sd-tag>, <sd-tag id="sdTag56" source="sdapi" category="None" entity_type="protein" role="assayed" text="IRF3" ext_ids="Q14653" ext_dbs="" in_caption="True" ext_names="IRF3" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">IRF3</sd-tag> and <sd-tag id="sdTag57" source="sdapi" category="None" entity_type="protein" role="assayed" text="STAT1" ext_ids="P42224" ext_dbs="" in_caption="True" ext_names="STAT1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">STAT1</sd-tag> <sd-tag id="sdTag58" source="sdapi" category="assay" entity_type="None" role="None" text="phosphorylation" ext_ids="BAO_0003005" ext_dbs="" in_caption="True" ext_names="phosphorylation assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">phosphorylation</sd-tag> sites are shown in red. <sd-tag id="sdTag59" source="sdapi" category="None" entity_type="protein" role="normalizing" text="Tubulin" ext_ids="Q71U36" ext_dbs="" in_caption="True" ext_names="TUBA1A" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">Tubulin</sd-tag> and <sd-tag id="sdTag60" source="sdapi" category="None" entity_type="protein" role="normalizing" text="GAPDH" ext_ids="P04406" ext_dbs="" in_caption="True" ext_names="GAPDH" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">GAPDH</sd-tag> <strong>were used as loading controls.</strong> <graphic href="https://api.sourcedata.io/file.php?panel_id=123973"/></sd-panel><sd-panel panel_id="123974"><sd-tag id="sdTag62" source="sdapi" category="None" entity_type="cell" role="component" text="H1299" ext_ids="CVCL_0060" ext_dbs="" in_caption="True" ext_names="NCI-H1299" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">H1299</sd-tag>+sh<sd-tag id="sdTag63" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA2" ext_ids="675" ext_dbs="" in_caption="True" ext_names="BRCA2" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA2</sd-tag><sup><sd-tag id="sdTag71" source="sdapi" category="None" entity_type="molecule" role="component" text="DOX" ext_ids="CHEBI:50845" ext_dbs="" in_caption="True" ext_names="doxycycline" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">DOX</sd-tag></sup> cells treated as in (B) were fixed and prepared for <sd-tag id="sdTag64" source="sdapi" category="assay" entity_type="None" role="None" text="immunofluorescence" ext_ids="BAO_0000450" ext_dbs="" in_caption="True" ext_names="fluorescence microscopy" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">immunofluorescence</sd-tag> with antibody against <sd-tag id="sdTag65" source="sdapi" category="None" entity_type="protein" role="assayed" text="cGAS" ext_ids="Q8N884" ext_dbs="" in_caption="True" ext_names="CGAS" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">cGAS</sd-tag>. <sd-pretag id="sdPretag1365081736sd" parent-tag-id="136">DNA</sd-pretag> was counterstained with <sd-tag id="sdTag66" source="sdapi" category="None" entity_type="molecule" role="reporter" text="DAPI" ext_ids="CHEBI:51231" ext_dbs="" in_caption="True" ext_names="DAPI" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">DAPI</sd-tag>. Scale bar represents 20 µm. Quantification of <sd-tag id="sdTag67" source="sdapi" category="None" entity_type="protein" role="assayed" text="cGAS" ext_ids="Q8N884" ext_dbs="" in_caption="True" ext_names="CGAS" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">cGAS</sd-tag>-positive <sd-tag id="sdTag68" source="sdapi" category="None" entity_type="subcellular" role="assayed" text="micronuclei" ext_ids="GO:0031040" ext_dbs="" in_caption="True" ext_names="micronucleus" ext_tax_ids="" ext_tax_names="" ext_urls="http://amigo.geneontology.org/amigo/term/">micronuclei</sd-tag> per cells shown in (E). Graph and error bars represent the mean and SEM of <strong>of</strong> <em>n</em> = 3 independent experiments. A minimum of 250 cells were analysed per condition per experiment. <em>P</em> values were calculated using an unpaired two-tailed <em>t</em>-test. *, <em>P</em> ≤ 0.05; **, <em>P</em> ≤ 0.01; <em>NS</em>, <em>P</em> &gt; 0.5. <graphic href="https://api.sourcedata.io/file.php?panel_id=123974"/></sd-panel></fig><fig id="45778"><title>.</title><label>Figure 3</label><graphic href="https://api.sourcedata.io/file.php?figure_id=45778"/><sd-panel panel_id="123976">FVB female <sd-tag id="sdTag72" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag> were injected intramuscularly with (A) <sd-tag id="sdTag73" source="sdapi" category="None" entity_type="gene" role="component" text="BRCA1" ext_ids="12189" ext_dbs="" in_caption="True" ext_names="Brca1" ext_tax_ids="10090" ext_tax_names="Mus musculus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA1</sd-tag>-proficient <sd-tag id="sdTag90" source="sdapi" category="None" entity_type="cell" role="assayed" text="KP3.33" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">KP3.33</sd-tag> (<sd-tag id="sdTag74" source="sdapi" category="None" entity_type="gene" role="component" text="Brca1" ext_ids="12189" ext_dbs="" in_caption="True" ext_names="Brca1" ext_tax_ids="10090" ext_tax_names="Mus musculus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>Brca</em>1</sd-tag><sup>+</sup>/<sup>+</sup>) or (B) <sd-tag id="sdTag75" source="sdapi" category="None" entity_type="gene" role="component" text="BRCA1" ext_ids="12189" ext_dbs="" in_caption="True" ext_names="Brca1" ext_tax_ids="10090" ext_tax_names="Mus musculus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA1</sd-tag>/<sd-tag id="sdTag76" source="sdapi" category="None" entity_type="gene" role="component" text="53BP1" ext_ids="27223" ext_dbs="" in_caption="True" ext_names="Trp53bp1" ext_tax_ids="10090" ext_tax_names="Mus musculus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">53BP1</sd-tag>-deficient <sd-tag id="sdTag77" source="sdapi" category="None" entity_type="cell" role="assayed" text="KB1PM5" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">KB1PM5</sd-tag> (<sd-tag id="sdTag78" source="sdapi" category="None" entity_type="gene" role="component" text="Brca1" ext_ids="12189" ext_dbs="" in_caption="True" ext_names="Brca1" ext_tax_ids="10090" ext_tax_names="Mus musculus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>Brca</em>1</sd-tag><sup>-</sup>/<sup>-</sup>, <em><sd-tag id="sdTag79" source="sdapi" category="None" entity_type="gene" role="component" text="Tp53bp1" ext_ids="27223" ext_dbs="" in_caption="True" ext_names="Trp53bp1" ext_tax_ids="10090" ext_tax_names="Mus musculus" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">Tp53bp1</sd-tag><sup>-/-</sup>)</em> <sd-tag id="sdTag80" source="sdapi" category="None" entity_type="organism" role="assayed" text="mouse" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mouse</sd-tag> <sd-tag id="sdTag81" source="sdapi" category="None" entity_type="tissue" role="component" text="mammary" ext_ids="UBERON:0001911" ext_dbs="" in_caption="True" ext_names="mammary gland" ext_tax_ids="" ext_tax_names="" ext_urls="https://www.ebi.ac.uk/ols/ontologies/uberon/terms?iri=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FUBERON_">mammary</sd-tag> tumour cells. <sd-tag id="sdTag82" source="sdapi" category="None" entity_type="molecule" role="intervention" text="Pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">Pyridostatin</sd-tag> (<sd-tag id="sdTag83" source="sdapi" category="None" entity_type="molecule" role="intervention" text="PDS" ext_ids="25227847" ext_dbs="" in_caption="True" ext_names="Pyridostatin" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">PDS</sd-tag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>) and <sd-tag id="sdTag84" source="sdapi" category="None" entity_type="molecule" role="intervention" text="talazoparib" ext_ids="135565082" ext_dbs="" in_caption="True" ext_names="Talazoparib" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">talazoparib</sd-tag> was administered orally (<em>p.o.; 0.33 mg/kg/day</em>), over the indicated periods of <sd-tag id="sdTag85" source="sdapi" category="time" entity_type="None" role="None" text="time" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">time</sd-tag>. Vertical dotted line indicates end of treatment. <sd-tag id="sdTag88" source="sdapi" category="assay" entity_type="None" role="None" text="Tumour volume" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">Tumour volume</sd-tag> was measured at the <sd-tag id="sdTag86" source="sdapi" category="time" entity_type="None" role="None" text="timepoints" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">timepoints</sd-tag> shown on the graph and expressed relative to <sd-tag id="sdTag89" source="sdapi" category="assay" entity_type="None" role="None" text="tumour volume" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">tumour volume</sd-tag> at the beginning of treatment. Each experimental group included <em>n</em> = 5 <sd-tag id="sdTag87" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag>. Error bars represent SEM. <em>P</em> values were calculated between treated and untreated tumours at day 16, using an unpaired two-tailed <em>t</em>-test. ****, <em>P</em> ≤ 0.0001; <em>NS</em>, <em>P</em> &gt; 0.5. <graphic href="https://api.sourcedata.io/file.php?panel_id=123976"/></sd-panel><sd-panel panel_id="123977">BRCA1-proficient KP3.33 (<em>Brca1</em><sup>+/+</sup>), BRCA1-deficient <sd-pretag id="sdPretag574134819sd" parent-tag-id="77">KB1PM5</sd-pretag> (<em>Brca1</em><sup>-/-</sup>) and BRCA1/<sd-pretag id="sdPretag6898613sd" type="geneprod" role="component">53BP1</sd-pretag>-deficient <sd-pretag id="sdPretag94667621sd" parent-tag-id="77">KB1PM5</sd-pretag> (<em>Brca1</em><sup>-/-</sup>/<sd-pretag id="sdPretag406138660sd" parent-tag-id="79"><em>Tp53bp1</em></sd-pretag><sup>-/-</sup>) mouse mammary tumour cells were treated with 2 µM <sd-pretag id="sdPretag2095537447sd" parent-tag-id="7">pyridostatin</sd-pretag> (<sd-pretag id="sdPretag1613770984sd" parent-tag-id="8">PDS</sd-pretag>) for 24 hours and released into fresh <sd-pretag id="sdPretag1713608718sd" type="undefined" role="component">medium</sd-pretag> without <sd-pretag id="sdPretag862221765sd" parent-tag-id="7">pyridostatin</sd-pretag>. Whole-cell extracts were prepared 0 to 72 hours after release and immunoblotted as indicated. <sd-pretag id="sdPretag1993070995sd" type="geneprod" role="normalizing">SMC1</sd-pretag> was used as a loading control. <sd-pretag id="sdPretag1771024129sd" type="geneprod" role="component">KAP1</sd-pretag> phosphorylation site is indicated in red. <graphic href="https://api.sourcedata.io/file.php?panel_id=123977"/></sd-panel><sd-panel panel_id="123978"><sd-tag id="sdTag91" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA1" ext_ids="672" ext_dbs="" in_caption="True" ext_names="BRCA1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA1</sd-tag><sup>+/+</sup>, <em><sd-tag id="sdTag92" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA1" ext_ids="672" ext_dbs="" in_caption="True" ext_names="BRCA1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA1</sd-tag></em><sup>-/-</sup> and <em><sd-tag id="sdTag93" source="sdapi" category="None" entity_type="gene" role="intervention" text="BRCA1" ext_ids="672" ext_dbs="" in_caption="True" ext_names="BRCA1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/">BRCA1</sd-tag></em><sup>-/-</sup>/<sd-tag id="sdTag94" source="sdapi" category="None" entity_type="gene" role="intervention" text="TP53BP1" ext_ids="7158" ext_dbs="" in_caption="True" ext_names="TP53BP1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="http://www.ncbi.nlm.nih.gov/gene/"><em>TP53BP1</em></sd-tag><sup>-/-</sup> <sd-tag id="sdTag95" source="sdapi" category="None" entity_type="cell" role="component" text="RPE-1" ext_ids="CVCL_4388&#10;" ext_dbs="" in_caption="True" ext_names="hTERT-RPE1&#10;" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://identifiers.org/cellosaurus:">RPE-1</sd-tag> cells were treated with 10 μM <sd-tag id="sdTag96" source="sdapi" category="None" entity_type="molecule" role="intervention" text="pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">pyridostatin</sd-tag> (<sd-tag id="sdTag97" source="sdapi" category="None" entity_type="molecule" role="intervention" text="PDS" ext_ids="25227847" ext_dbs="" in_caption="True" ext_names="Pyridostatin" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">PDS</sd-tag>) or 2 μM <sd-tag id="sdTag98" source="sdapi" category="None" entity_type="molecule" role="intervention" text="olaparib" ext_ids="CHEBI:83766" ext_dbs="" in_caption="True" ext_names="olaparib" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=">olaparib</sd-tag> for 2 days. Whole-cell extracts were <sd-tag id="sdTag99" source="sdapi" category="assay" entity_type="None" role="None" text="immunoblotted" ext_ids="BAO_0002422" ext_dbs="" in_caption="True" ext_names="immunoblot" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">immunoblotted</sd-tag> as indicated. <sd-tag id="sdTag100" source="sdapi" category="None" entity_type="protein" role="assayed" text="KAP1" ext_ids="Q13263" ext_dbs="" in_caption="True" ext_names="TRIM28" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">KAP1</sd-tag>, <sd-tag id="sdTag101" source="sdapi" category="None" entity_type="protein" role="assayed" text="IRF3" ext_ids="Q14653" ext_dbs="" in_caption="True" ext_names="IRF3" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">IRF3</sd-tag> and <sd-tag id="sdTag102" source="sdapi" category="None" entity_type="protein" role="assayed" text="STAT1" ext_ids="P42224" ext_dbs="" in_caption="True" ext_names="STAT1" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">STAT1</sd-tag> <sd-tag id="sdTag103" source="sdapi" category="assay" entity_type="None" role="None" text="phosphorylation" ext_ids="BAO_0003005" ext_dbs="" in_caption="True" ext_names="phosphorylation assay" ext_tax_ids="" ext_tax_names="" ext_urls="https://bioportal.bioontology.org/ontologies/BAO/?p=classes&amp;conceptid=http%3A%2F%2Fwww.bioassayontology.org%2Fbao%23">phosphorylation</sd-tag> sites are shown in red. <sd-tag id="sdTag104" source="sdapi" category="None" entity_type="protein" role="normalizing" text="SMC1" ext_ids="Q14683" ext_dbs="" in_caption="True" ext_names="SMC1A" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">SMC1</sd-tag> and <sd-tag id="sdTag105" source="sdapi" category="None" entity_type="protein" role="normalizing" text="GAPDH" ext_ids="P04406" ext_dbs="" in_caption="True" ext_names="GAPDH" ext_tax_ids="9606" ext_tax_names="Homo sapiens" ext_urls="https://www.uniprot.org/uniprot/">GAPDH</sd-tag> <strong>were used as loading controls.</strong> <graphic href="https://api.sourcedata.io/file.php?panel_id=123978"/></sd-panel></fig><fig id="45779"><title>.</title><label>Figure 4</label><graphic href="https://api.sourcedata.io/file.php?figure_id=45779"/><sd-panel panel_id="123979">A Dose-dependent viability assays of PDTCs derived from <sd-pretag id="sdPretag1341362680sd" type="tissue" role="component">breast</sd-pretag> cancer samples (Bruna <em>et al.</em>, 2016) treated with <sd-pretag id="sdPretag1245840221sd" parent-tag-id="7">pyridostatin</sd-pretag> (<sd-pretag id="sdPretag658091022sd" parent-tag-id="8">PDS</sd-pretag>) at the indicated doses. Values from <em>n</em> = 2 independent experiments are shown. AB521: ER-negative tumour, no <sd-pretag id="sdPretag1526489129sd" type="geneprod" role="component"><em>BRCA1</em></sd-pretag> alteration; VHIO179: tumour with <sd-pretag id="sdPretag1002404140sd" type="geneprod" role="component"><em>BRCA1</em></sd-pretag> germline mutation and <em>MAD2L2</em> inactivating mutation (<sd-pretag id="sdPretag557448831sd" parent-tag-id="98">olaparib</sd-pretag>-resistant). <graphic href="https://api.sourcedata.io/file.php?panel_id=123979"/></sd-panel><sd-panel panel_id="123980">B VHIO179 PDTXs were grafted into CB17-<sd-tag id="sdTag108" source="sdapi" category="disease" entity_type="None" role="None" text="SCID" ext_ids="DOID:627" ext_dbs="" in_caption="True" ext_names="severe combined immunodeficiency" ext_tax_ids="" ext_tax_names="" ext_urls=" https://identifiers.org/">SCID</sd-tag> female <sd-tag id="sdTag109" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag>. <sd-tag id="sdTag110" source="sdapi" category="None" entity_type="molecule" role="intervention" text="Pyridostatin" ext_ids="117064504" ext_dbs="" in_caption="True" ext_names="Pyridostatin Trifluoroacetate" ext_tax_ids="" ext_tax_names="" ext_urls="https://pubchem.ncbi.nlm.nih.gov/compound/">Pyridostatin</sd-tag> was administered intravenously (<em>7.5 mg/kg/day</em>) over the indicated periods of <sd-tag id="sdTag111" source="sdapi" category="time" entity_type="None" role="None" text="time" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">time</sd-tag>. Vertical dotted line indicates end of treatment. <sd-tag id="sdTag112" source="sdapi" category="assay" entity_type="None" role="None" text="Tumour volume" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">Tumour volume</sd-tag> was measured at the <sd-tag id="sdTag113" source="sdapi" category="time" entity_type="None" role="None" text="timepoints" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">timepoints</sd-tag> shown on the graph and expressed relative to <sd-tag id="sdTag114" source="sdapi" category="assay" entity_type="None" role="None" text="tumour volume" ext_ids="" ext_dbs="" in_caption="True" ext_names="" ext_tax_ids="" ext_tax_names="" ext_urls="">tumour volume</sd-tag> at the beginning of treatment. Each experimental group included <em>n</em> = 7 <sd-tag id="sdTag115" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag>. Error bars represent SEM. <em>P</em> values were calculated between treated and untreated tumours at day 24, using an unpaired two-tailed <em>t</em>-test. ****, <em>P</em> ≤ 0.0001<em>.</em> <graphic href="https://api.sourcedata.io/file.php?panel_id=123980"/></sd-panel></fig><fig id="45780"><title>.</title><label>Figure 5</label><graphic href="https://api.sourcedata.io/file.php?figure_id=45780"/><sd-panel panel_id="123981">Pyridostatin (<sd-pretag id="sdPretag1143439657sd" parent-tag-id="8">PDS</sd-pretag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>) and NU-7441 was administered intraperitoneally (<em>i.p.;</em> 10 mg/kg/day), over the indicated periods of <sd-pretag id="sdPretag134520150sd" parent-tag-id="85">time</sd-pretag>. Vertical dashed line indicates end of treatment. Tumour volume was measured at the timepoints shown on the graph and expressed relative to tumour volume at the beginning of treatment. Each experimental group included <em>n</em> = 5 <sd-pretag id="sdPretag1317024827sd" type="organism" role="component">mice</sd-pretag>. Error bars represent SEM. <em>P</em> values were calculated at day 39 using an unpaired two-tailed <em>t</em>-test, between treated and untreated tumours, or between the NU-7441+<sd-pretag id="sdPretag1540909514sd" parent-tag-id="8">PDS</sd-pretag> combination and each single treatment. **, <em>P</em> ≤ 0.01; ***, <em>P</em> ≤ 0.001; ****, <em>P</em> ≤ 0.0001. <graphic href="https://api.sourcedata.io/file.php?panel_id=123981"/></sd-panel><sd-panel panel_id="123982">Pyridostatin (<sd-pretag id="sdPretag7240623sd" parent-tag-id="8">PDS</sd-pretag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>) over the indicated periods of <sd-pretag id="sdPretag2005468881sd" parent-tag-id="85">time</sd-pretag>, and paclitaxel (PACLI) was administered intravenously (<em>i.v</em>.; 20 mg/kg/day) on indicated single days. Vertical dashed line indicates end of treatment. Tumour volume was measured at the timepoints shown on the graph and expressed relative to tumour volume at the beginning of treatment. Each experimental group included <em>n</em> = 5 <sd-pretag id="sdPretag202690551sd" type="organism" role="component">mice</sd-pretag>. Error bars represent SEM. <em>P</em> values were calculated at day 39 using an unpaired two-tailed <em>t</em>-test, between treated and untreated tumours, or between the <sd-pretag id="sdPretag55513784sd" parent-tag-id="8">PDS</sd-pretag>+PACLI combination and each single treatment. **, <em>P</em> ≤ 0.01; ***, <em>P</em> ≤ 0.001; ****, <em>P</em> ≤ 0.0001. <graphic href="https://api.sourcedata.io/file.php?panel_id=123982"/></sd-panel><sd-panel panel_id="123984">Pyridostatin (<sd-pretag id="sdPretag1824347162sd" parent-tag-id="8">PDS</sd-pretag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>), NU-7441 was administered intraperitoneally (<em>i.p.;</em> 10 mg/kg/day), over the indicated periods of <sd-pretag id="sdPretag1364500781sd" parent-tag-id="85">time</sd-pretag>, and paclitaxel (PACLI) was administered intravenously (<em>i.v</em>.; 20 mg/kg/day) on indicated single days. Vertical dashed line indicates end of treatment. Tumour volume was measured at the timepoints shown on the graph and expressed relative to tumour volume at the beginning of treatment. Each experimental group included <em>n</em> = 5 <sd-pretag id="sdPretag1421090633sd" type="organism" role="component">mice</sd-pretag>. Error bars represent SEM. <em>P</em> values were calculated at day 63 using an unpaired two-tailed <em>t</em>-test between the NU-7441+<sd-pretag id="sdPretag1493163333sd" parent-tag-id="8">PDS</sd-pretag>+PACLI combination and each double treatment. ****, <em>P</em> ≤ 0.0001. <graphic href="https://api.sourcedata.io/file.php?panel_id=123984"/></sd-panel><sd-panel panel_id="123983"><sd-tag id="sdTag123" source="sdapi" category="assay" entity_type="None" role="None" text="Kaplan-Meier survival curve" ext_ids="OBI_0200088" ext_dbs="" in_caption="True" ext_names="Kaplan Meier" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ontobee.org/ontology/OBI?iri=http://purl.obolibrary.org/obo/">Kaplan-Meier survival curve</sd-tag> for <sd-tag id="sdTag124" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag> treated as in (C), with each treatment group containing <em>n</em> = 5 <sd-tag id="sdTag125" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag>. Statistical significance was assessed by Log-rank test (****<em>P</em> &lt;0.0001). <graphic href="https://api.sourcedata.io/file.php?panel_id=123983"/></sd-panel></fig><fig id="45781"><title>.</title><label>Figure 6</label><graphic href="https://api.sourcedata.io/file.php?figure_id=45781"/><sd-panel panel_id="123985">Pyridostatin (<sd-pretag id="sdPretag917505957sd" parent-tag-id="8">PDS</sd-pretag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>) and NU-7441 was administered intraperitoneally (<em>i.p.;</em> 10 mg/kg/day), over the indicated periods of <sd-pretag id="sdPretag1097629152sd" parent-tag-id="85">time</sd-pretag>. Vertical dashed line indicates end of treatment. Tumour volume was measured at the timepoints shown on the graph and expressed relative to tumour volume at the beginning of treatment. Each experimental group included <em>n</em> = 6 <sd-pretag id="sdPretag1189107313sd" type="organism" role="component">mice</sd-pretag>. Error bars represent SEM. <em>P</em> values were calculated at day 24 using an unpaired two-tailed <em>t</em>-test <em>N.S. P&gt; 0.5;</em> **, <em>P</em> ≤ 0.01; ****, <em>P</em> ≤ 0.0001. <graphic href="https://api.sourcedata.io/file.php?panel_id=123985"/></sd-panel><sd-panel panel_id="123986">Pyridostatin (<sd-pretag id="sdPretag1838630731sd" parent-tag-id="8">PDS</sd-pretag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>) over the indicated periods of <sd-pretag id="sdPretag1106599661sd" parent-tag-id="85">time</sd-pretag>, and paclitaxel (PACLI) was administered intravenously (<em>i.v</em>.; 20 mg/kg/day) on indicated single days. Vertical dashed line indicates end of treatment. Tumour volume was measured at the timepoints shown on the graph and expressed relative to tumour volume at the beginning of treatment. Each experimental group included <em>n</em> = 6 <sd-pretag id="sdPretag1299291895sd" type="organism" role="component">mice</sd-pretag>. Error bars represent SEM. <em>P</em> values were calculated at day 24 using an unpaired two-tailed <em>t</em>-test ****, <em>P</em> ≤ 0.0001. <graphic href="https://api.sourcedata.io/file.php?panel_id=123986"/></sd-panel><sd-panel panel_id="123987">Pyridostatin (<sd-pretag id="sdPretag1857422sd" parent-tag-id="8">PDS</sd-pretag>) was administered intravenously (<em>i.v.; 7.5 mg/kg/day</em>), NU-7441 was administered intraperitoneally (<em>i.p.;</em> 10 mg/kg/day), over the indicated periods of <sd-pretag id="sdPretag247929630sd" parent-tag-id="85">time</sd-pretag>, and paclitaxel (PACLI) was administered intravenously (<em>i.v</em>.; 20 mg/kg/day) on indicated single days. Vertical dashed line indicates end of treatment. Tumour volume was measured at the timepoints shown on the graph and expressed relative to tumour volume at the beginning of treatment. Each experimental group included <em>n</em> = 6 <sd-pretag id="sdPretag509322062sd" type="organism" role="component">mice</sd-pretag>. Error bars represent SEM. <em>P</em> values were calculated at day 36 or 38 using an unpaired two-tailed <em>t</em>-test ****, <em>P</em> ≤ 0.0001. <graphic href="https://api.sourcedata.io/file.php?panel_id=123987"/></sd-panel><sd-panel panel_id="123988"><sd-tag id="sdTag129" source="sdapi" category="assay" entity_type="None" role="None" text="Kaplan-Meier survival curve" ext_ids="OBI_0200088" ext_dbs="" in_caption="True" ext_names="Kaplan Meier" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ontobee.org/ontology/OBI?iri=http://purl.obolibrary.org/obo/">Kaplan-Meier survival curve</sd-tag> for <sd-tag id="sdTag130" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag> treated as in (C), with each treatment group containing <em>n</em> = 6 <sd-tag id="sdTag131" source="sdapi" category="None" entity_type="organism" role="assayed" text="mice" ext_ids="10090" ext_dbs="" in_caption="True" ext_names="Mus musculus" ext_tax_ids="" ext_tax_names="" ext_urls="http://www.ncbi.nlm.nih.gov/taxonomy/">mice</sd-tag>. Statistical significance was assessed by Log-rank test (****<em>P</em> &lt;0.0001). <graphic href="https://api.sourcedata.io/file.php?panel_id=123988"/></sd-panel></fig></article>